These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Effect of bolus length of intraarterial injections on contrast-enhanced MR-angiography in patients. Author: Hashagen C, Schulte AC, Bongartz G, Aschwanden M, Jaeger KA, Huegli R, Jacob AL, Bilecen D. Journal: J Magn Reson Imaging; 2007 Apr; 25(4):841-7. PubMed ID: 17345642. Abstract: PURPOSE: To perform MR-guided interventions, repetitive injections of contrast agent in the arterial system are necessary. By reducing the intraarterial bolus length during image acquisition and consecutively reducing the gadolinium-chelate-based contrast agent dose, we focus on a comparable vascular depiction. The tradeoff in reducing bolus length is vascular depiction. MATERIALS AND METHODS: Intraarterial gadolinium-chelate injection was performed to depict the femoropopliteal artery and infrapopliteal arteries in six patients. Six measurements with a bolus length of 20% to 100% of the total acquisition time were performed (three-dimensional [3D] Turbo-fast low-angle shot (FLASH) sequence, 1.5 T). Contrast-to-noise ratio (CNR) was determined and a consensus reading of vascular depiction was performed. RESULTS: CNR values comparable 100% of bolus length were obtained for the femoropopliteal artery at >or=40% and for the infrapopliteal arteries at >or=60%. Qualitative analysis demonstrated that a bolus length of >or=60% is necessary to reveal a good diagnostic vascular depiction. CONCLUSION: Quantitatively, a reduction of intraarterial gadolinium-chelate dosage in patients is possible down to 40% in the femoropopliteal artery and to 60% in the infrapopliteal arteries to acquire a CNR comparable to 100% of bolus length. Qualitatively, however, the bolus length can only be reduced down to 60% for both level to produce a good diagnostic vascular depiction and is, for diagnostic purposes, the limiting factor.[Abstract] [Full Text] [Related] [New Search]